Header cover image
  • Investing Ideas
  • Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

May & Baker Nigeria

Market Cap: ₦88.8b

May & Baker Nigeria Plc, junto con sus filiales, fabrica, vende y distribuye productos farmacéuticos humanos, vacunas humanas y productos de consumo en Nigeria.

MAYBAKER

₦51.50

7D

19.9%

1Y

294.6%